Antileukemic activity and cellular effects of the antimalarial agent artesunate in acute myeloid leukemia
This study investigates the antileukemic activity of artesunate, an antimalarial drug, in acute myeloid leukemia (AML). The results show that artesunate effectively inhibits AML cell proliferation and induces apoptosis through reactive oxygen species (ROS) generation and mitochondrial dysfunction. These findings suggest that artesunate may serve as a promising therapeutic agent
June 26, 2025
No Comments